Carbon Nanotubes-Based Assays for Cancer Detection and Screening
Related Experiment Video
Updated: Sep 26, 2025
Fabrication of Carbon Nanotube High-Frequency Nanoelectronic Biosensor for Sensing in High Ionic Strength Solutions
Published on: July 22, 2013
Cristina Bura1, Teodora Mocan1,2, Cristiana Grapa1,2
1Nanomedicine Department, Regional Institute of Gastroenterology and Hepatology ''Octavian Fodor'', 400008 Cluj-Napoca, Romania.
Abstract:
Carbon nanotubes (CNTs) were considered a potential cargo for cancer therapy and diagnosis following researchers' shared goal of finding a new delivery system to enhance the pharmacological performance of the administered drugs. To date, several excellent reviews have focused on the role of CNTs as drug delivery systems, although there is currently no existing study that gathers all the advances in research-connected carbon nanotubes-based assay development for the early detection of cancer. In this review article, we will focus on the emerging role of CNTs as anticancer detection agents.
Insights
Carbon nanotubes (CNTs) show promise for early cancer detection. This review explores their emerging role as anticancer detection agents, distinct from their use in drug delivery.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Carbon nanotubes (CNTs) are explored for enhanced drug delivery in cancer therapy.
- Existing reviews focus on CNTs for drug delivery, not cancer detection assays.
- There is a need to consolidate research on CNTs for early cancer diagnosis.
Purpose of the Study:
- To review the advances in carbon nanotube-based assay development for early cancer detection.
- To highlight the emerging role of CNTs as anticancer detection agents.
Main Methods:
- Comprehensive literature review of studies on carbon nanotubes in cancer detection.
- Analysis of research connecting CNTs to assay development for cancer diagnosis.
Main Results:
- CNTs offer unique properties suitable for sensitive cancer biomarker detection.
- Various CNT-based assay formats are being developed for different cancer types.
- Research indicates potential for improved early cancer detection using CNTs.
Conclusions:
- Carbon nanotubes represent a promising platform for developing novel early cancer detection assays.
- Further research is needed to translate CNT-based detection methods into clinical practice.
- CNTs are emerging as crucial tools in the fight against cancer through early diagnosis.
